Use of glucocorticoids megadoses in SARS-CoV-2 infection in a spanish registry: SEMI-COVID-19

ObjectiveTo describe the impact of different doses of corticosteroids on the evolution of patients with COVID-19 pneumonia, based on the potential benefit of the non-genomic mechanism of these drugs at higher doses.MethodsObservational study using data collected from the SEMI-COVID-19 Registry. We e...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 17; no. 1; p. e0261711
Main Authors Cristina Lavilla Olleros, Cristina Ausín García, Alejandro David Bendala Estrada, Ana Muñoz, Philip Erick Wikman Jogersen, Ana Fernández Cruz, Vicente Giner Galvañ, Juan Antonio Vargas, José Miguel Seguí Ripoll, Manuel Rubio-Rivas, Rodrigo Miranda Godoy, Luis Mérida Rodrigo, Eva Fonseca Aizpuru, Francisco Arnalich Fernández, Arturo Artero, Jose Loureiro Amigo, Gema María García García, Luis Corral Gudino, Jose Jiménez Torres, José-Manuel Casas-Rojo, Jesús Millán Núñez-Cortés, SEMI-COVID-19 Network
Format Journal Article
LanguageEnglish
Published Public Library of Science (PLoS) 01.01.2022
Online AccessGet full text

Cover

Loading…